Today in News History
On July 13, several notable moments in the history of News stand out. In 1755, Edward Braddock, Scottish general (born 1695) passed away. In 1929, Sofia Muratova, Russian gymnast (died 2006) was born. In 1934, Peter Gzowski, Canadian journalist and academic (died 2002) was born. In 1976, Sheldon Souray, Canadian ice hockey player was born. In 1983, Gabrielle Roy, Canadian engineer and author (born 1909) passed away. In 1985, Vice President George H. W. Bush becomes the Acting President for the day when President Ronald Reagan undergoes surgery to remove polyps from his colon. In 1985, Charlotte Dujardin, English equestrian was born. In 1990, Lenin Peak disaster: a 6.4-magnitude earthquake in Afghanistan triggers an avalanche on Lenin Peak, killing 43 climbers in the deadliest mountaineering disaster in history. In 2007, Lamine Yamal, Spanish footballer was born. In 2010, George Steinbrenner, American businessman (born 1930) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.
Canada approves 1st generic semaglutide shot for weight loss

It's the third generic semaglutide product approved by the department, though the first two were authorized for the treatment of Type 2 diabetes in adults.
Narrative Intelligence Brief
This article was published by Global News, a source frequently categorized with a center bias based in Canada. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of Global News, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.
More from Global News
July 13, 2026
‘Jurassic Park’ actor Sam Neill dead at 78
July 13, 2026
Who controls the Strait of Hormuz? U.S., Iran make competing claims
July 13, 2026
Ticks are spreading anaplasmosis, not just Lyme disease, CMA warns
July 13, 2026
Iran-backed group behind anti-Jewish attacks, U.K. says
July 13, 2026
Air Canada, technicians union sign new tentative agreement
Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.More Coverage
Discussion
"cup"
How other outlets are covering this story
Compare narratives across 41 related reports from 41 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.
Coverage bias distribution
41 sources
Left 39%
Center 32%
Right 22%
Canada's National Observer
· Jun 30, 2026
Canada approves the first generic semaglutide injection for weight loss
Health Canada has approved the first generic semaglutide injection for weight loss.
Now Magazine
· Jul 3, 2026
Here’s a look at SEVMIA, the first generic weight-loss injection approved by Health Canada
What to know Health Canada approved the first generic version of the weight-loss drug Wegovy. Here’s what it means for those seeking to lose weight... The post Here’s a look at SEVMIA, the first generic weight-loss injection approved by Health Canada appeared first on NOW Toronto.
PolitiFact
· Jul 1, 2026
A patient got the weight loss medication retatrutide before FDA approval. How does that work?
A primer on retatrutide and compassionate use
Washington Examiner
· Jul 10, 2026
Big Kratom wants Trump to ban 7-OH. Here’s the truth he needs to hear
On June 30, the Drug Enforcement Administration took steps to temporarily ban 7-hydroxymitragynine (7-OH) products nationwide. You might think this is about public safety — but as a recent article showed, the kratom industry has been pushing bans like this because it doesn’t like the 7-OH competition. But for folks like me, living with chronic []
CityNews Montreal
· Jun 24, 2026
Health Canada approves weight-loss drug for sleep apnea in patients with obesity
Health Canada has approved weight-loss drug Zepbound for treating obstructive sleep apnea in adults with obesity. The department confirmed that the authorization granted on June 11 makes Zepbound the only GLP-1 drug in Canada approved for the sleep disorder that causes people to stop breathing temporarily because their upper airway is blocked. That blockage can [] The post Health Canada approves weight-loss drug for sleep apnea in patients with obesity appeared first on CityNews Montreal.
CNBC
· Jul 11, 2026
A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss
Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and diabetes counterpart Ozempic.
Gizmodo
· Jul 8, 2026
11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy
15 of Americans have ever taken the drugs, up from 6 in 2024.
Mashable
· Jul 9, 2026
GLP-1s are inescapable online. Heres why thats a problem.
Weight loss is big business on social media — and some are paying a price.
Metro
· Jul 7, 2026
I swapped my usual bodycare for E45’s new HydroCell range for 30 days – the results surprised me
I have sensitive skin and E45's new HydroCell products impressed me.
Canadian Centre for Policy Alternatives
· Jun 26, 2026
With Bill 11, Alberta is creating a two-tier system that will kill public health care
Why is the federal government allowing Alberta to flagrantly violate the Canada Health Act? The post With Bill 11, Alberta is creating a two-tier system that will kill public health care appeared first on CCPA.
Investing.com
· Jul 8, 2026
Form 144 Bicara Therapeutics Inc. For: 8 July
Form 144 Bicara Therapeutics Inc. For: 8 July
Daily Mail
· Jun 21, 2026
We've already lost 15lb on the new Wegovy weight-loss pill that's cheaper than jabs. Here's everything you need to know about how to get it, side effects - and the trick to turbocharge your weight loss with no extra effort
We've already lost 15lb on the new Wegovy weight-loss pill that's cheaper than jabs. Here's everything you need to know about how to get it, side effects - and the trick to turbocharge your weight loss with no extra effort
Kaiser Health
· Jun 26, 2026
Trouble Getting Weight Loss Drugs Covered by Insurance? Here’s What To Know
If your doctor prescribes a GLP-1 medication for weight loss but your insurance won’t cover it, you have options.
Foreign Policy Journal
· Jun 26, 2026
Novo Nordisk (CPSE:NOVO B) Secures UK Approval For Once-Daily Oral Wegovy Pill, Reshaping Obesity Treatment Access
Novo Nordisk (CPSE:NOVO B) has received UK regulatory approval for an oral version of Wegovy, making it the first authorized daily GLP-1 pill for weight management in the country. The approval covers obese and overweight adults, providing a meaningful alternative to injectable GLP-1 therapies that have dominated the obesity treatment landscape. The decision is expected [] The post Novo Nordisk (CPSE:NOVO B) Secures UK Approval For Once-Daily Oral Wegovy Pill, Reshaping Obesity Treatment Access appeared first on Foreign Policy Journal.
Health News | Mail Online
· Jul 2, 2026
The 75p supplement that could turbo-charge your weight loss: Drug-free pill can mimic the effect of fat jabs by silencing food cravings
The 75p supplement that could turbo-charge your weight loss: Drug-free pill can mimic the effect of fat jabs by silencing food cravings
Medical Daily
· Jul 2, 2026
A New Drug Just Became the First Approved for Both Active and Chronic Thyroid Eye Disease
FDA approved veligrotug (Lumvoa) for both active and chronic thyroid eye disease — a first. Here's who qualifies, what the evidence shows, and what changes for the 50,000–100,000 Americans affected annually.
Voice of Nigeria
· Jun 29, 2026
FDA Reviews Sandoz Generic Obesity Drug Applications
The U.S. Food and Drug Administration (FDA) has accepted for review two generic versions of tirzepatide developed by Swiss pharmaceutical company Sandoz, a move that could pave the way for increased competition in the rapidly expanding obesity and diabetes treatment market. If approved, the medicines would become direct competitors to Eli Lilly’s blockbuster tirzepatide brands, [] The post FDA Reviews Sandoz Generic Obesity Drug Applications appeared first on Voice of Nigeria.
Loonie Politics
· Jul 9, 2026
Canada objects to Olympics loosening restrictions on Russia athletes amid Ukraine war
OTTAWA — Canada is objecting to the International Olympic Committee loosening its suspension on Russian athletes. The move would apply to the 2028 games in Los Angeles, opening the door for Russian athletes to compete, but the IOC says it will decide later if they could do it with the Russian flag and anthem. Secretary [] The post Canada objects to Olympics loosening restrictions on Russia athletes amid Ukraine war appeared first on Loonie Politics.
The New Zealand Herald
· Jul 13, 2026
These New Hair Loss Treatments Are An Alternative To Surgery. But Do They Work?
These New Hair Loss Treatments Are An Alternative To Surgery. But Do They Work?
NBC News
· Jun 30, 2026
Supreme Court agrees to hear challenge to assault weapon bans
The Supreme Court on Tuesday agreed to decide whether states and local governments can ban semiautomatic rifles like the AR-15, which are popular among gun enthusiasts but have also been used in high-profile mass shootings.
Hello Magazine
· Jul 6, 2026
I've been on GLP-1s for 16 months – here's why I won't be swapping to the new weight loss pill
Weight loss drug Wegovy is finally available in pill form, making it more accessible to people who want the benefits of GLP-1s – but is it worth making the swap?
QuintDaily
· Jun 25, 2026
Discover the Transformative Benefits of HIFU Treatment for Non-Surgical Facelifts
Amongst contemporary beauty treatments, the quest for youthful skin has actually acquired an entire new form with the introduction of hifu treatment. HIFU, or High-Intensity Focused Ultrasound, is a technology that can give people a chance to rejuvenate their skin without having to resort to surgical procedures. What is HIFU Treatment? HIFU is the latest [] The post Discover the Transformative Benefits of HIFU Treatment for Non-Surgical Facelifts appeared first on QuintDaily.
Proto Thema - English
· Jul 1, 2026
Obesity: Free medication program ends as Health Ministry seeks two-month extension
If the extension is not approved, the disruption will affect only July and August, as the entire Prevent program is expected to resume with national funding from September, the Prime Minister announced at the ygeiamou.gr health conference The post Obesity: Free medication program ends as Health Ministry seeks two-month extension appeared first on ProtoThema English.
ScienceDaily
· Jul 8, 2026
New weight loss pill beats oral Ozempic in major trial
A new once-daily weight-loss pill called orforglipron delivered better weight loss and blood sugar improvements than the leading oral semaglutide in a major clinical trial. The tablet could offer a more convenient alternative to injectable drugs like Ozempic and Wegovy because it doesn't require refrigeration or special timing with meals. It's also cheaper to manufacture, which could expand access globally.
Seeking Alpha
· Jul 9, 2026
Teva Pharmaceutical Industries Limited (TEVA) Discusses Anti-IL-15 Antibody Phase Ib 24-Week Efficacy Results in Vitiligo and Planned Advancement to Phase 2b - Slideshow
Teva Pharmaceutical Industries Limited (TEVA) Discusses Anti-IL-15 Antibody Phase Ib 24-Week Efficacy Results in Vitiligo and Planned Advancement to Phase 2b - Slideshow
ABC7 New York
· Jun 24, 2026
These are the best Prime Day deals on beauty essentials
Snag these deeply discounts on skincare, makeup and other beauty essentials during Prime Day.
Brisbane Times
· Jul 8, 2026
Weightloss injectable to become more accessible for Australians
Doctors say a pill version of the weightloss injectable Wegovy will make treatment more accessible for Australians.
Dr. Malcolm Kendrick
· May 19, 2026
WEGOVY THE WONDER DRUG
Lose weight, reduce the risk of CV disease – unless you are taking Wegovy? [A tale of mystery and intrigue unfolds]. A lot of people have asked me about the weight loss drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 agonists) e.g. Wegovy (semaglutide), or Mounjaro (tirzepatide). What do I think of them, are they []
The News Letter
· Jul 8, 2026
Editorial: Stormont's conversion therapy ban proposal needs careful scrutiny
News Letter editorial for Thursday, July 9, 2026:
The Daily Beast
· Jun 22, 2026
I Tried Lyma’s New ID² Power Gut Bio Complex for a Month—Here’s What Happened
LYMAAll products are selected independently by The Looker’s editors. If you click or purchase something from our post, we may earn a small commission.Lyma, a premium beauty and wellness company with multiple patented products, recently launched ID² Power Gut Bio Complex. According to the brand, this daily, drinkable supplement was developed based on 50 years of longevity research.It promises to “nourish your entire gastrointestinal system” with bioavailable forms of various micronutrients, omega-3s, and four types of prebiotic fiber. But what exactly is Lyma ID², exactly, and is it actually worth its hefty price tag?Read more at The Daily Beast.
The Eastern Herald
· Jul 5, 2026
FDA Clears a Transplant Therapy Built to Cut Chronic GVHD From 44% to 13%
The FDA approved Tregzi, Orca Bio's engineered cell therapy, after a 187-patient trial found it cut moderate-to-severe chronic graft-versus-host disease from 44 with standard transplants to 13. The tradeoff patients now face is a newer therapy without years of follow-up data behind it.
Sweden Herald
· Jul 7, 2026
Government gives SEK 120 million in new support for child vaccinations
Government gives SEK 120 million in new support for child vaccinations
Wired
· Jun 27, 2026
Duer’s Wear-Everywhere Pants Are on Sale This Weekend
It’s not often you can score discounts from the outdoor-coded Canadian company that makes understated and stylish performance clothing.
NPR Topics: Health
· Jun 22, 2026
Trouble getting weight loss drugs covered by insurance? Here's what to know
What to do if your insurance denies your obesity drug.
CNET
· Jul 13, 2026
Meta Pulls Instagram AI Update After Everyone Said They Didn't Want to Be Deepfaked
We've heard the feedback that this feature missed the mark, Meta wrote in a blog post.
Global News
· Jun 30, 2026
After N.B. law, all 10 provinces now have job protection for long-term sick leave
With New Brunswick's new unpaid sick leave law, all 10 provinces in Canada now have some sort of job protection for people who need extended time off for serious illnesses.
Los Angeles Times
· Jun 30, 2026
Supreme Court will decide a gun-rights challenge to blue-state bans on assault weapons
California's long-standing ban on semiautomatic assault rifles could be struck down by the Supreme Court.
People.com
· Jul 5, 2026
I’m Replacing My Worn-Out Swimwear with These Supportive One-Pieces and Bikinis — and They're All Under $40
Stock up for your next warm-weather getaway
The Moscow Times
· Jul 13, 2026
World Table Tennis Body Reinstates Russian Players With Flag and Anthem
The move follows the International Olympic Committee’s decision last week to provisionally lift its suspension of the Russian Olympic Committee.
Globes English
· Jul 7, 2026
Teva reports positive skin treatment drug results
The Israeli company reported in the study that patients showed improvements in skin pigmentation with vitiligo.
9 News Australia
· Jul 8, 2026
The weightloss pill that could change the game for Aussies | 9 News Australia
Doctors say a pill version of the weightloss injectable Wegovy will make treatment more accessible for Australians. It's just been launched in the UK, but the green light is yet to be given by Australia's medical watchdog for two oral GLP-1 medications. #9News | Subscribe and 🔔: http://9Soci.al/KM6e50GjSK9 | Get more breaking news at nine.com.au FOLLOW 9News Australia ► Facebook: https://www.facebook.com/9News/ ► X: https://twitter.com/9NewsAUS ► Instagram: https://www.instagram.com/9news/ ► TikTok: https://www.tiktok.com/@9news Join 9News for the latest in news and events that affect you in your local city, as well as news from across Australia and the world. #BREAKINGNEWS #9NEWS #AUSTRALIA
Topics:
Related coverage for "Canada approves 1st generic semaglutide shot for weight loss": Canada's National Observer — Canada approves the first generic semaglutide injection for weight loss. Now Magazine — Here’s a look at SEVMIA, the first generic weight-loss injection approved by Health Canada. PolitiFact — A patient got the weight loss medication retatrutide before FDA approval. How does that work?. Washington Examiner — Big Kratom wants Trump to ban 7-OH. Here’s the truth he needs to hear. CityNews Montreal — Health Canada approves weight-loss drug for sleep apnea in patients with obesity. CNBC — A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss. Gizmodo — 11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy. Mashable — GLP-1s are inescapable online. Heres why thats a problem.. Metro — I swapped my usual bodycare for E45’s new HydroCell range for 30 days – the results surprised me. Canadian Centre for Policy Alternatives — With Bill 11, Alberta is creating a two-tier system that will kill public health care. Investing.com — Form 144 Bicara Therapeutics Inc. For: 8 July. Daily Mail — We've already lost 15lb on the new Wegovy weight-loss pill that's cheaper than jabs. Here's everything you need to know about how to get it, side effects - and the trick to turbocharge your weight loss with no extra effort. Kaiser Health — Trouble Getting Weight Loss Drugs Covered by Insurance? Here’s What To Know. Foreign Policy Journal — Novo Nordisk (CPSE:NOVO B) Secures UK Approval For Once-Daily Oral Wegovy Pill, Reshaping Obesity Treatment Access. Health News | Mail Online — The 75p supplement that could turbo-charge your weight loss: Drug-free pill can mimic the effect of fat jabs by silencing food cravings. Medical Daily — A New Drug Just Became the First Approved for Both Active and Chronic Thyroid Eye Disease. Voice of Nigeria — FDA Reviews Sandoz Generic Obesity Drug Applications. Loonie Politics — Canada objects to Olympics loosening restrictions on Russia athletes amid Ukraine war. The New Zealand Herald — These New Hair Loss Treatments Are An Alternative To Surgery. But Do They Work? . NBC News — Supreme Court agrees to hear challenge to assault weapon bans. Hello Magazine — I've been on GLP-1s for 16 months – here's why I won't be swapping to the new weight loss pill. QuintDaily — Discover the Transformative Benefits of HIFU Treatment for Non-Surgical Facelifts. Proto Thema - English — Obesity: Free medication program ends as Health Ministry seeks two-month extension. ScienceDaily — New weight loss pill beats oral Ozempic in major trial. Seeking Alpha — Teva Pharmaceutical Industries Limited (TEVA) Discusses Anti-IL-15 Antibody Phase Ib 24-Week Efficacy Results in Vitiligo and Planned Advancement to Phase 2b - Slideshow. ABC7 New York — These are the best Prime Day deals on beauty essentials . Brisbane Times — Weightloss injectable to become more accessible for Australians. Dr. Malcolm Kendrick — WEGOVY THE WONDER DRUG. The News Letter — Editorial: Stormont's conversion therapy ban proposal needs careful scrutiny. The Daily Beast — I Tried Lyma’s New ID² Power Gut Bio Complex for a Month—Here’s What Happened. The Eastern Herald — FDA Clears a Transplant Therapy Built to Cut Chronic GVHD From 44% to 13%. Sweden Herald — Government gives SEK 120 million in new support for child vaccinations. Wired — Duer’s Wear-Everywhere Pants Are on Sale This Weekend. NPR Topics: Health — Trouble getting weight loss drugs covered by insurance? Here's what to know. CNET — Meta Pulls Instagram AI Update After Everyone Said They Didn't Want to Be Deepfaked. Global News — After N.B. law, all 10 provinces now have job protection for long-term sick leave. Los Angeles Times — Supreme Court will decide a gun-rights challenge to blue-state bans on assault weapons. People.com — I’m Replacing My Worn-Out Swimwear with These Supportive One-Pieces and Bikinis — and They're All Under $40. The Moscow Times — World Table Tennis Body Reinstates Russian Players With Flag and Anthem. Globes English — Teva reports positive skin treatment drug results. 9 News Australia — The weightloss pill that could change the game for Aussies | 9 News Australia


